期刊文献+

喉癌组织中VEGF-C及其受体VEGFR-3和D2-40的表达及意义 被引量:3

Expression and significance of VEGF-C,VEGFR-3 and D2-40 in laryngeal squamous cell carcinoma
在线阅读 下载PDF
导出
摘要 目的观察血管内皮生长因子C(VEGF-C)及其受体(VEGFR-3)和D2-40在喉癌组织中的表达情况,探讨其在喉癌淋巴道转移过程中的作用及可能机制。方法选择喉癌患者的癌组织、癌旁正常组织标本各40份,同期选择正常喉组织标本19份作对照。采用免疫组织化学法检测各标本中VEGF-C、VEGFR-3和D2-40的表达。结果 VEGF-C、VEGFR-3及D2-40在喉癌组织、癌旁组织及正常喉组织中均有表达,且其表达强度呈下降趋势(H分别为38.400、32.502,P均<0.01);在喉癌组织中,VEGF-C、VEGFR-3及D2-40的表达与淋巴转移、临床分期及临床分型有关(P均<0.05),与病理分级、肿瘤大小、吸烟量、年龄和性别无关(P均>0.05)。喉癌组织中VEGF-C与VEGFR-3的表达呈正相关(r=0.882,P<0.01)。结论 VEGF-C、VEGFR-3及D2-40在喉癌组织中的表达均明显高于癌旁组织及正常喉组织,其高表达可能与喉癌的发生、发展有关。 Objective To observe the expression of the vascular endothelial growth factor C (VEGF-C) , vascular en- dothelial growth factor receptor 3 (VEGFR-3) and D2-40 in the laryngeal squamous cell carcinoma, and to investigate its function and mechanism in the process of lymph node metastasis of laryngeal carcinoma. Methods The expression of VEGF-C, VEGFR-3 and D2-40 was detected by immunohistochemistry in 40 cases of laryngeal carcinoma tissues, 40 cases of para-carcinoma tissues and 19 cases of normal laryngeal mucosa tissues as controls. Results There was the expression of VEGF-C, VEGFR-3 and D2-40 in laryngeal carcinoma tissues, para-carcinoma tissues and normal laryngeal mucosa tis- sues, and the expression showed a declining tendency ( H = 38. 400, 32. 502, respectively; all P 〈 0.01 ). In the laryngeal carcinoma tissues, the expression of VEGF-C, VEGFR-3 and D2-40 was correlated with lymph node metastasis, clinical stages and clinical classification (all P 〈 0.05 ), but it wash t correlated with pathological grading of tumor, tumor size, smoking history, patients' age and sex ( all P 〉 0.05 ) ; the expression of VEGF-C was positively correlated with the expression of VEGFR-3 (r = 0.882, P 〈 O. 01 ). Conclusions The expression of VEGF-C, VEGFR-3 and D2-40 in laryngeal carcinoma tissues is significantly higher than that in the para-carcinoma tissues and normal laryngeal mucosa tissues, whose high expression may be related to the carcinogenesis and development of laryngeal carcinoma.
出处 《山东医药》 CAS 2013年第41期4-7,共4页 Shandong Medical Journal
基金 河北省卫生厅医学科学研究重点课题(03012) 河北省普通高校强势特色学科重点建设项目
关键词 喉肿瘤 血管内皮生长因子受体 D2-40 肿瘤转移 免疫组织化学 laryngeal neoplasms vascular endothelial growth factor C vascular endothelial growth factor receptor D2-40 neoplasm metastasis immunohistochemistry
  • 相关文献

参考文献14

  • 1Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the progression of breast cancer[J] .Hum Pathol,1987,18 (12):1268-1275.
  • 2Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J] .Breast Cancer Res Treat,1996,36 (2):169-180.
  • 3姜自彬,李元.血管内皮生长因子受体的研究进展[J].国外医学(药学分册),2001,28(1):9-13. 被引量:4
  • 4Joukov V,Pajusola K,Kaipainen A,et al.A novel vascular endothelial growth factor,VEGF-C,is a ligand for the Flt4 (EGFR-3)and KDR (VEGFR-2) receptor tyrosine kinases[J] .EMBO J,1996,15(2):290-298.
  • 5Kukk E,Lymboussaki A,Taira S,et al.VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development[J] .Development,1996,122(12):3829-3837.
  • 6Fukunaga M.Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours[J] .Histopathology,2005,46(4):396-402.
  • 7王向红,张占薪,张占化,陈奎生.宫颈鳞癌组织中VEGF-C、VEGFR-3的表达变化及意义[J].山东医药,2009,49(26):38-39. 被引量:6
  • 8Sithanandam G,Smith GT,Masuda A,et al.Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol3-kinase/Akt athway[J] .Carcinogenesis,2005,24 (10):1581-1592.
  • 9Testa JR,Bellacosa A.AKT plays a central role in tumorigenesis[J] .Proc Natl Acad Sci USA,2001,98(20):10983-10985.
  • 10Cheng JC,Chou CH,Kuo ML,et al.Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction athway[J] .Oncogene,2006,25(53):7009-7018.

二级参考文献33

  • 1Yi-TaoJia,Zhong-XinLi,Yu-TongHe,WeiLiang,Hui-ChaiYang,Hong-JunMa.Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer[J].World Journal of Gastroenterology,2004,10(22):3261-3263. 被引量:28
  • 2[1]Ergün S, Kilic N, Fiedler W, et al. Vascular endothelial growth factor and its receptor in normal human testicular tissue[J]. Mol Cell Endocrinol, 1997,131(1):9-20.
  • 3[2]Gerber HP, Condorelli F, Park J, et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes[J]. J Biol Chem, 1997, 272(38):23659 - 23667.
  • 4[3]Suzuki H, Seto K, Shinoda Y, et al. Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed Hep G2 cells[J]. Am J Physiol, 1999,276(1): G92 - G97.
  • 5[4]Brogi E, Schatteman G, Wu T, et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression[J]. J Clin Invest, 1996, 97(2):469-476.
  • 6[5]Hata Y, Duh E, Zhang K, et al. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence [ J ]. J Biol Chem, 1998, 273(30): 19294- 19303.
  • 7[6]Giraudo E, Primo L, Audero E, et al. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells [ J]. J Biol Chem, 1998, 273(34) :22128 - 22135.
  • 8[7]Patterson C, Perrella MA, Endege WO, et al. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells [J]. J Clin Invest, 1996, 98(2) :490 - 496.
  • 9[8]de Vries C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase,a receptor for vascular endothelial growth factor[J]. Science, 1992, 255(5047) :989- 991.
  • 10[9]Terman BI, Dougher-Vermazen M, Carrion ME, et al.Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor[J]. Biochem Biophys Res Commun, 1992, 187(3): 1579 - 1586.

共引文献10

同被引文献25

  • 1许大巍.喉鳞癌患者血浆MMP-9及VEGF-C检测的临床意义[J].中国保健营养,2014,24(4):109-110.
  • 2Guski H,Hufnagl P,Kaufmann O,et al.AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast[J].Anal Quant Cytol Histol,2000,22(3):206-212.
  • 3Hirakawa S,Brown L F,Kodarna S,et al.VEGF-C induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites[J].Blood,2007,109(3):1010-1017.
  • 4Han L,Su W,Huang J,et al.Doxycycline inhibits inflammation-induced lymphangiogenesis in mouse cornea by multiple mechanisms[J].PLoS One,2014,30,9(9):e108931.
  • 5Sophia Ran,Lisa Volk,Kelly Hall,Michael J. Flister.Lymphangiogenesis and lymphatic metastasis in breast cancer[J]. Pathophysiology . 2009 (4)
  • 6Joukov V,Palusola K,Kaipainen A,et al.A novel vascular endothelial growht factor, VEGF- c, is a ligant for Flt- 4 (VEGFR- 3)and KDR ( VEGFR - 2 ) receptor tyrosine kinases. EMBO Journal . 1996
  • 7Hirakawa Satoshi,Brown Lawrence F,Kodama Shohta,Paavonen Karri,Alitalo Kari,Detmar Michael.VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood . 2006
  • 8徐志华,王继群,张涛,贾海英,孙瑾,山艳春.VEGF在喉癌中表达的Meta分析[J].山东大学耳鼻喉眼学报,2008,22(1):32-34. 被引量:3
  • 9成伟,梁中敏.喉癌组织微血管密度及血管形成相关因子的检测及临床意义[J].河北医学,2008,14(12):1393-1397. 被引量:2
  • 10王海涛,金宏林,王莹,金春顺.CXCR4和VEGF-C在喉癌中的表达及与淋巴结转移的关系[J].中国老年学杂志,2009,29(3):340-342. 被引量:3

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部